Entering text into the input field will update the search result below

Retrophin secures financing

May 29, 2014 5:25 PM ETTravere Therapeutics, Inc. (TVTX) StockBy: Douglas W. House, SA News Editor
  • Retrophin (RTRX -7.5%) closes a $40M senior secured term loan facility provided by Athyrium Capital Management. The loan will mature in 2018 and carry an interest rate of LIBOR + 10%. Athyrium will receive warrants to purchase 300K shares at $13.93/share for five years.
  • The company also closes the sale of $40M of 4.5% Senior Convertible Notes due May 30, 2019 to institutional investors. The conversion rate is 57.43 shares of common per $1,000 principal amount equating to an initial conversion price of $17.41.

Recommended For You

More Trending News

About TVTX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
TVTX--
Travere Therapeutics, Inc.